SBL Vaccines is specialised in the development, manufacture and marketing of vaccines and niche pharmaceuticals. The primary research focus is the field of diarrhoeal diseases. In the Nordic region, SBL Vaccines markets a complete vaccine portfolio sourced from global vaccine companies. SBL Vaccines' core product Dukoral® is an oral vaccine that protects against cholera and ETEC, causing what is commonly known as travellers´ diarrhoea. Dukoral is licensed and available worldwide